BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 32697965)

  • 21. Watch-and-Wait as a Strategy for Appropriately Selected Rectal Cancer Patients.
    Hunt SR
    J Am Coll Surg; 2020 Dec; 231(6):692-694. PubMed ID: 33243398
    [No Abstract]   [Full Text] [Related]  

  • 22. Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by
    Zhu J; Liu A; Sun X; Liu L; Zhu Y; Zhang T; Jia J; Tan S; Wu J; Wang X; Zhou J; Yang J; Zhang C; Zhang H; Zhao Y; Cai G; Zhang W; Xia F; Wan J; Zhang H; Shen L; Cai S; Zhang Z
    J Clin Oncol; 2020 Dec; 38(36):4231-4239. PubMed ID: 33119477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological characteristics and survival outcomes for patients with mucinous colorectal cancer liver metastases undergoing hepatic resection: A systematic review and meta-analysis.
    Reynolds IS; Cromwell PM; Hoti E
    Am J Surg; 2021 Sep; 222(3):529-535. PubMed ID: 33750573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When is a Ghost Really Gone? A Systematic Review and Meta-analysis of the Accuracy of Imaging Modalities to Predict Complete Pathological Response of Colorectal Cancer Liver Metastases After Chemotherapy.
    Muaddi H; Silva S; Choi WJ; Coburn N; Hallet J; Law C; Cheung H; Karanicolas PJ
    Ann Surg Oncol; 2021 Oct; 28(11):6805-6813. PubMed ID: 33772391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant chemotherapy in stage II and III colon cancer: the role of the "budding and TILs-(tumor-infiltrating lymphocytes) combination" as tumor-host antagonists.
    Lang-Schwarz C; Melcher B; Dregelies T; Norouzzadeh Z; Rund-Küffner S; Lang-Schwarz K; Vieth M; Sterlacci W
    Int J Colorectal Dis; 2021 Aug; 36(8):1765-1779. PubMed ID: 33745027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome.
    Bogner A; Fritzmann J; Müssle B; Huber J; Dobroschke J; Bork U; Wolk S; Distler M; Weitz J; Welsch T; Kahlert C
    Int J Colorectal Dis; 2021 Aug; 36(8):1701-1710. PubMed ID: 33677655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study.
    Behrenbruch C; Prabhakaran S; Udayasiri D D; Michael M; Hollande F; Hayes I; Heriot AG; Knowles B; Thomson BN
    J Surg Oncol; 2021 Apr; 123(5):1263-1273. PubMed ID: 33524184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial.
    Meattini I; Marrazzo L; Saieva C; Desideri I; Scotti V; Simontacchi G; Bonomo P; Greto D; Mangoni M; Scoccianti S; Lucidi S; Paoletti L; Fambrini M; Bernini M; Sanchez L; Orzalesi L; Nori J; Bianchi S; Pallotta S; Livi L
    J Clin Oncol; 2020 Dec; 38(35):4175-4183. PubMed ID: 32840419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
    Huang WS; Kuan FC; Lin MH; Chen MF; Chen WC
    Ann Surg Oncol; 2020 Oct; 27(11):4309-4318. PubMed ID: 32794029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fully semantic segmentation for rectal cancer based on post-nCRT MRl modality and deep learning framework.
    Xia S; Li Q; Zhu HT; Zhang XY; Shi YJ; Yang D; Wu J; Guan Z; Lu Q; Li XT; Sun YS
    BMC Cancer; 2024 Mar; 24(1):315. PubMed ID: 38454349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?
    Daprà V; Airoldi M; Bartolini M; Fazio R; Mondello G; Tronconi MC; Prete MG; D'Agostino G; Foppa C; Spinelli A; Puccini A; Santoro A
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key clinical trials in rectal cancer shaping the current treatment paradigms: reference guide for radiologists.
    Paroder V; Fraum TJ; Nougaret S; Petkovska I; Rauch GM; Kaur H
    Abdom Radiol (NY); 2023 Sep; 48(9):2825-2835. PubMed ID: 37221342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis.
    Kucharczyk MJ; Bang A; Tjong MC; Papatheodorou S; Fabregas JC
    Oncotarget; 2022 Oct; 13():1109-1119. PubMed ID: 36251013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodal Treatment of Rectal Cancer.
    Ghadimi M; Rödel C; Hofheinz R; Flebbe H; Grade M
    Dtsch Arztebl Int; 2022 Aug; 119(33-34):570-580. PubMed ID: 35791271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation.
    Iv AA; Koprowski MA; Nabavizadeh N; Tsikitis VL
    Ann Gastroenterol; 2022; 35(3):226-233. PubMed ID: 35599927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer.
    Bhudia J; Glynne-Jones R
    Curr Treat Options Oncol; 2022 Apr; 23(4):453-473. PubMed ID: 35312962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients.
    Zhang J; Zhang L; Gou Y; Diao P; Hu Y
    Sci Rep; 2022 Mar; 12(1):4286. PubMed ID: 35277532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Low anterior resection syndrome-Causes and treatment approaches].
    Stelzner S; Kupsch J; Mees ST
    Chirurg; 2021 Jul; 92(7):612-620. PubMed ID: 33877394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.
    Ruppert R; Kube R; Strassburg J; Lewin A; Baral J; Maurer CA; Sauer J; Junginger T; Hermanek P; Merkel S;
    J Am Coll Surg; 2020 Oct; 231(4):413-425.e2. PubMed ID: 32697965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial.
    Ruppert R; Junginger T; Ptok H; Strassburg J; Maurer CA; Brosi P; Sauer J; Baral J; Kreis M; Wollschlaeger D; Hermanek P; Merkel S;
    Br J Surg; 2018 Oct; 105(11):1519-1529. PubMed ID: 29744860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.